Inactivation of influenza virus haemagglutinin by chlorine dioxide: oxidation of the conserved tryptophan 153 residue in the receptor-binding site

References

1. Akamatsu A., Lee C., Morino H., Miura T., Ogata N., Shibata T. 2012; Six-month low level chlorine dioxide gas inhalation toxicity study with two-week recovery period in rats. J Occup Med Toxicol 7:2 [View Article][PubMed]
   [Google Scholar]
2. Biemann K. 1988; Contributions of mass spectrometry to peptide and protein structure. Biomed Environ Mass Spectrom 16:99–111 [View Article][PubMed]
   [Google Scholar]
3. Gamblin S. J., Skehel J. J. 2010; Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285:28403–28409 [View Article][PubMed]
   [Google Scholar]
4. Herrmann B. 1978; [Production of influenza virus recombinations]. Arch Exp Veterinarmed 32:455–464 (in German) [PubMed]
   [Google Scholar]
5. Kallin E., Lönn H., Norberg T. 1986; New derivatization and separation procedures for reducing oligosaccharides. Glycoconj J 3:311–319 [View Article]
   [Google Scholar]
6. Knossow M., Skehel J. J. 2006; Variation and infectivity neutralization in influenza. Immunology 119:1–7 [View Article][PubMed]
   [Google Scholar]
7. Lin T., Wang G., Li A., Zhang Q., Wu C., Zhang R., Cai Q., Song W., Yuen K.-Y. 2009; The hemagglutinin structure of an avian H1N1 influenza A virus. Virology 392:73–81 [View Article][PubMed]
   [Google Scholar]
8. Martín J., Wharton S. A., Lin Y. P., Takemoto D. K., Skehel J. J., Wiley D. C., Steinhauer D. A. 1998; Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 241:101–111 [View Article][PubMed]
   [Google Scholar]
9. Meisner J., Szretter K. J., Bradley K. C., Langley W. A., Li Z.-N., Lee B.-J., Thoennes S., Martin J., Skehel J. J.other authors 2008; Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice. J Virol 82:5079–5083 [View Article][PubMed]
   [Google Scholar]
10. Morino H., Matsubara A., Fukuda T., Shibata T. 2007; [Inhibition of hyphal growth of the fungus Alternaria alternata by chlorine dioxide gas at very low concentrations]. Yakugaku Zasshi 127:773–777 (in Japanese) [View Article][PubMed]
    [Google Scholar]
11. Morino H., Fukuda T., Miura T., Lee C., Shibata T., Sanekata T. 2009; Inactivation of feline calicivirus, a norovirus surrogate, by chlorine dioxide gas. Biocontrol Sci 14:147–153 [View Article][PubMed]
    [Google Scholar]
12. Morino H., Fukuda T., Miura T., Shibata T. 2011; Effect of low-concentration chlorine dioxide gas against bacteria and viruses on a glass surface in wet environments. Lett Appl Microbiol 53:628–634 [View Article][PubMed]
    [Google Scholar]
13. Napolitano M. J., Green B. J., Nicoson J. S., Margerum D. W. 2005; Chlorine dioxide oxidations of tyrosine, N-acetyltyrosine, and dopa. Chem Res Toxicol 18:501–508 [View Article][PubMed]
    [Google Scholar]
14. Ogata N. 2007; Denaturation of protein by chlorine dioxide: oxidative modification of tryptophan and tyrosine residues. Biochemistry 46:4898–4911 [View Article][PubMed]
    [Google Scholar]
15. Ogata N., Shibata T. 2008; Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection. J Gen Virol 89:60–67 [View Article][PubMed]
    [Google Scholar]
16. Ogata N., Shibata T. 2009; Effect of chlorine dioxide gas of extremely low concentration on absenteeism of schoolchildren. Int J Med Med Sci 1:288–289
    [Google Scholar]
17. Sanekata T., Fukuda T., Miura T., Morino H., Lee C., Maeda K., Araki K., Otake T., Kawahata T., Shibata T. 2010; Evaluation of the antiviral activity of chlorine dioxide and sodium hypochlorite against feline calicivirus, human influenza virus, measles virus, canine distemper virus, human herpesvirus, human adenovirus, canine adenovirus and canine parvovirus. Biocontrol Sci 15:45–49 [View Article][PubMed]
    [Google Scholar]
18. Sauter N. K., Glick G. D., Crowther R. L., Park S. J., Eisen M. B., Skehel J. J., Knowles J. R., Wiley D. C. 1992; Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. Proc Natl Acad Sci U S A 89:324–328 [View Article][PubMed]
    [Google Scholar]
19. Skehel J. J., Wiley D. C. 2000; Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569 [View Article][PubMed]
    [Google Scholar]
20. Stevens J., Corper A. L., Basler C. F., Taubenberger J. K., Palese P., Wilson I. A. 2004; Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866–1870 [View Article][PubMed]
    [Google Scholar]
21. Stevens J., Blixt O., Tumpey T. M., Taubenberger J. K., Paulson J. C., Wilson I. A. 2006; Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404–410 [View Article][PubMed]
    [Google Scholar]
22. Stewart D. J., Napolitano M. J., Bakhmutova-Albert E. V., Margerum D. W. 2008; Kinetics and mechanisms of chlorine dioxide oxidation of tryptophan. Inorg Chem 47:1639–1647 [View Article][PubMed]
    [Google Scholar]
23. Xie Y., Gong J., Li M., Fang H., Xu W. 2011; The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase. Curr Med Chem 18:1050–1066 [View Article][PubMed]
    [Google Scholar]
24. Yang Z.-Y., Wei C.-J., Kong W.-P., Wu L., Xu L., Smith D. F., Nabel G. J. 2007; Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317:825–828 [View Article][PubMed]
    [Google Scholar]